Glycomine has concluded subject enrolment in the Phase IIb POLAR study of GLM101 to treat phosphomannomutase 2 congenital ...
A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
UNION BRIDGE, MD, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- Veteran Clinical Research Executive and Consultant ...
4d
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today announced that a Phase II Clinical Trial of ...
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a ...
This Study explores several new DehydraTECH enhancements not previously evaluated, which include but are not limited to the ...
MTX240 is a molecular glue, bringing two intracellular proteins, PDE3a and SLFN12, specifically co-expressed by GIST cancer cells, into close proximity to form a stable complex. This interaction ...
A groundbreaking study validates BabyOrgano Baalprashan, showing a 44% improvement in child wellbeing and significant ...
The Hearty Soul on MSN
Ancient herb known as "nature's valium" is garnering attention for how it improves sleep and anxiety, according to studies & clinical trials
Millions of adults reach for sleep aids or anti-anxiety medications each year, but a growing number are looking at what has ...
Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.
The University of Rochester Medical Center is celebrating the grand reopening of its Clinical Research Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results